Results of an open-label study of high-dose liposomal amphotericin B (AmBisome) in the treatment of confirmed fungal infections in high-risk patients

被引：0
作者：
Kinsey, S
Jackson, G
Holyoake, T
McCann, S
Gibson, B
机构：
[1] St James Hosp, Dept Paediat Haematol, Leeds LS9 7TF, W Yorkshire, England
[2] Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[3] Glasgow Royal Infirm, Dept Haematol, Glasgow G4 0SF, Lanark, Scotland
[4] St James Hosp, Dept Haematol, Dublin 8, Ireland
[5] Royal Hosp Sick Children, Dept Haematol, Glasgow G3 8SJ, Lanark, Scotland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2004年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
202
引用
收藏
页码：62 / 63
页数：2
相关论文
共 50 条
[41]   Nebulised amphotericin B as an adjunct to high dose IV amphotericin B in the treatment of fungal pneumonia in immunocompromised patients. A pilot study. [J].
Simpson, DR ;
Fung, HC ;
Ostrow, DN ;
Shepherd, JD ;
Nantel, SH ;
Sutherland, HJ ;
Klingemann, HG ;
Toze, CL ;
Barnett, MJ .
BLOOD, 1995, 86 (10) :3851-3851
[42]   Prevention of invasive fungal infections in liver transplant recipients:: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients [J].
Fortún, J ;
Martín-Dávila, P ;
Moreno, S ;
Bárcena, R ;
de Vicente, E ;
Honrubia, A ;
García, M ;
Nuño, J ;
Candela, A ;
Uriarte, M ;
Pintado, V .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) :813-819
[43]   High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV: a randomised study [J].
Bicanic, T. ;
Meintjes, G. ;
Wood, R. ;
Rebe, K. ;
Brouwer, A. ;
Bekker, L-G. ;
Harrison, T. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 :S34-S34
[44]   Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study [J].
Sundar, Shyam ;
Pandey, Krishna ;
Thakur, Chandreshwar Prasad ;
Jha, Tara Kant ;
Das, Vidya Nand Ravi ;
Verma, Neena ;
Lal, Chandra Shekhar ;
Verma, Deepak ;
Alam, Shahnawaz ;
Das, Pradeep .
PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (09)
[45]   High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: An open-label feasibility study [J].
Nogueira, Raul G. ;
Bodock, Michael J. ;
Koroshetz, Walter J. ;
Topcuoglu, Mehmet A. ;
Carter, Bob S. ;
Ogilvy, Christopher S. ;
Pryor, Johnny C. ;
Buonanno, Ferdinando S. .
NEUROCRITICAL CARE, 2007, 7 (03) :194-202
[46]   High-dose Bosentan in the Prevention and Treatment of Subarachnoid Hemorrhage-induced Cerebral Vasospasm: An Open-label Feasibility Study [J].
Raul G. Nogueira ;
Michael J. Bodock ;
Walter J. Koroshetz ;
Mehmet A. Topcuoglu ;
Bob S. Carter ;
Christopher S. Ogilvy ;
Johnny C. Pryor ;
Ferdinando S. Buonanno .
Neurocritical Care, 2007, 7 :194-202
[47]   An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: Preliminary evidence for treatment efficacy [J].
Rosse, RB ;
Kendrick, K ;
FayMcCarthy, M ;
Prell, GD ;
Rosenberg, P ;
Tsui, LC ;
Wyatt, RJ ;
Deutsch, SI .
CLINICAL NEUROPHARMACOLOGY, 1996, 19 (04) :341-348
[48]   High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: An open-label pilot study [J].
Nogueira, RG ;
Topcuoglu, MA ;
Koroshetz, WJ ;
Betensky, RA ;
Bodock, MJ ;
O'Donnell, J ;
Buckley, DA ;
Amin-Hanjani, S ;
Carter, BS ;
Ogilvy, CS ;
Buonanno, FS .
STROKE, 2004, 35 (01) :332-333
[49]   Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles [J].
De la Serna, Javier ;
Jarque, Isidro ;
Lopez-Jimenez, Javier ;
Maria Fernandez-Navarro, Jose ;
Gomez, Valle ;
Jurado, Manuel ;
Pascual, Adriana ;
Serrano, Josefina ;
Romero, Monica ;
Vallejo, Carlos .
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2013, 26 (01) :64-69
[50]   Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles [J].
Perez de Oteyza, Jaime .
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016, 29 :26-27
12345